Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Arthur A Ciociola"'
Publikováno v:
American Journal of Gastroenterology. 107:501-504
How the FDA Manages Drug Safety With Black Box Warnings, Use Restrictions, and Drug Removal, With Attention to Gastrointestinal Medications
Publikováno v:
Alimentary Pharmacology & Therapeutics. 20:975-982
Summary Background : The rapid onset and symptomatic response to histamine-2 receptor antagonists prior to the pharmacological effect on acid secretion suggests a different mechanism of action. Aim : To determine if ranitidine decreases oesophageal s
Publikováno v:
Alimentary Pharmacology & Therapeutics. 16:1317-1326
Summary Background : No standard methods exist for determining the onset of action of gastric antisecretory agents in human subjects. Methods : Intragastric pH was measured when placebo, ranitidine 150 mg, ranitidine 75 mg or famotidine 10 mg were ad
Autor:
K. Fung, H. M. Faessel, W. R. Treem, J. A. McGuire, B. U. K. Li, Joel E. Lavine, J. L. Blumer, Arthur A. Ciociola, S. R. Orenstein, J. E. Grunow
Publikováno v:
Alimentary Pharmacology & Therapeutics. 16:899-907
Background: The use of over-the-counter antacids has increased in children under the age of 12 years, and has been followed by an apparent increase in the use of over-the-counter histamine-2 receptor antagonists. However, the pharmacokinetic and phar
Publikováno v:
Journal of Applied Physiology. 92:427-434
Measurement of meal- stimulated gastric acid secretion using manual intragastric titration is demanding in terms of personnel and specialized equipment. In the present study, we used a new method, in vivo gastric autotitration, to determine meal-stim
Autor:
Arthur A. Ciociola, Philip B. Miner, Sheila Rodriguez-Stanley, Sattar Zubaidi, Malcolm Robinson, Jonathan Filinto, Jerry D. Gardner
Publikováno v:
Digestive Diseases and Sciences. 47:265-273
In some patients, proton pump inhibitors do not abolish nocturnal gastric acidity and additional evening antisecretory medication may be required. In 16 subjects with chronic heartburn, 24-hr gastric and esophageal pH were measured at baseline and ag
Autor:
Arthur A Ciociola, Lawrence B Cohen, Prasad Kulkarni, Costas Kefalas, Alan Buchman, Carol Burke, Tedd Cain, Jason Connor, Eli D Ehrenpreis, John Fang, Ronnie Fass, Robyn Karlstadt, Dan Pambianco, Joseph Phillips, Mark Pochapin, Paul Pockros, Philip Schoenfeld, Raj Vuppalanchi
Publikováno v:
The American journal of gastroenterology. 109(5)
This article provides an overview of FDA's regulatory processes for drug development and approval, and the estimated costs associated with the development of a drug, and also examines the issues and challenges facing the FDA in the near future.A lite
Publikováno v:
The American journal of gastroenterology. 109(10)
Food and Drug Administration (FDA) advisory panels and committees play a critical role in advising the FDA on the safety and efficacy of medical devices and drugs marketed in the US. Advisory panel recommendations are used by the FDA to make decision
Publikováno v:
American Journal of Therapeutics. 8:387-398
Introduction A study of the consumer's understanding of the product label instructions and the resulting product use were conducted to support the switch of a product from prescription to nonprescription status. H2 receptor antagonists have recently
Publikováno v:
American Journal of Therapeutics. 8:399-408
Background: Many Americans have heartburn or related symptoms monthly and >20% experience heartburn at least once per day. Although many self-treat episodic heartburn with nonprescription antacids, newer treatments that decrease gastric volume and in